Core components

The chimeric antigen receptor (CAR)-Modified T-cell (CAR-T) has led to a new chapter in cancer treatment, which is the latest contribution of antibody engineering to better human health. Taking ScFv a

<m met-id=86 met-table=news met-field=keywords></m>

The chimeric antigen receptor (CAR)-Modified T-cell (CAR-T) has led to a new chapter in cancer treatment, which is the latest contribution of antibody engineering to better human health. Taking ScFv as the main form (which is like the "eye" of a CAR-T), the EXCYTE antibody library provides the tumor specific ScFv and core components for any CAR-T project.